Givlaari™ (givosiran) for the Treatment of Acute Hepatic Porphyria

Givlaari™ (givosiran) is a ALAS1-directing RNAi therapeutic indicated to treat acute hepatic porphyria (AHP) in adults. Credit: Business Wire.



  • Givlaari™
  • Givlaari™
  • Givlaari™